People around the world will need to get a jab against Covid-19 once a year, at least when it comes to the Pfizer vaccine, BioNTech’s CEO Ugur Sahin said in an interview on Sunday, as he praised the quality of its booster shot.
In an interview with Germany’s Bild newspaper on Sunday, Sahin said he considers the vaccine, co-developed by his company, to be “very effective.”
Asking people if they should be concerned about the “breakthrough infections” – in which those vaccinated with the Pfizer-BioNTech vaccine still developed Covid-19 symptoms – he dismissed such concerns, saying that the jab offers a “90 percent protection”cases that need intensive care for those older than 60 years.
“very high”BioNTech CEO said that this protection is good for nine months. This level begins to decrease, he stated. “from the fourth month,” however. Sahin strongly advocated booster shots in order to preserve the protection. “to break … chains of infection.”
He encouraged physicians to also be “as pragmatic as possible”Greenlighting vaccines is a matter of course “not to send people home unvaccinated even though they could be vaccinated without any problems.”
According to BioNTech’s CEO, booster shots may be required once per year in the future. The BioNTech CEO stated that the booster shot will offer protection to his patients. “last longer”More than the first immunity acquired after two doses.
“Subsequent … vaccinations may only be needed every year – just like [with] influenza,”He stated. Currently, the German Federal Center for Health Education – an agency subordinated to the Health Ministry – recommends a booster shot six months after one gets the second dose of a vaccine. According to it, the booster shot should be taken six months following the first dose. “booster vaccination makes sense after a minimum interval of about four months.”
Sahin’s interview comes days after it was revealed that Pfizer, BioNTech and Moderna are making a combined profit of $65,000 every minute – all thanks to their Covid-19 jabs. That is according to estimates made by the People’s Vaccine Alliance (PVA) – a coalition demanding wider access to vaccines.
PVA estimatedThe three companies will earn $34 billion combined in pre-tax profits for this year. This roughly equals to more than 1,000 per second or $93.5 million per day.
PVA has condemned the three companies’ refusal to accept vaccine technology transfer in spite of receiving $8 billion each from public funding. According to the coalition, such a move could boost global supply and help save many lives. It also would lower prices.
“Pfizer, BioNTech and Moderna have used their monopolies to prioritize the most profitable contracts with the richest governments, leaving low-income countries out in the cold,” said Maaza Seyoum of the African Alliance and People’s Vaccine Alliance Africa.
You think your friends might be interested in this story? This story is your chance to share it!